EU Finance Day for Businesses

Our CEO Eva Kovacova presented Glycanostic’s success story as well as learnings and experience with the EIC Accelerator scheme during the EU Finance Day for Businesses organized by the European Commission Services & Representations.

More News

Až okolo 14 percent pacientov s rakovinou prostaty zachytíme na Slovensku v pokročilom štádiu ochorenia. Foto N – Tomáš Benedikovič

New project: € 2.5 mil. funding signed for Novel serological glycan-based biomarkers for screening of breast, lung and pancreatic cancers

June 2023

EU Workshop on Innovation and Technology Transfer in Central and Southeast Europe

May 2022

EIC Corporate DAy Fresenius Kabi and Medtronic

EIC Corporate Day with Medtronic and Fresenius Kabi

November 2022

Glycanostics s.r.o.

Kudlákova 7
841 01 Bratislava
Slovakia

We are an innovative start-up company ready to reimagine medicine via early stage, highly accurate and unique cancer diagnostics.

Glycanostics, s.r.o. currently implements project ProSCAN co-financed by Horizon Europe programme, GA number 190185443 and an APVV project ProGlyCan funded via grant agreement number APVV-20-0476.